2025-02-26 ZTO Express (Cayman) Inc. HaiPress
SHANGHAI,Feb. 25,2025 -- ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) ("ZTO" or the "Company"),a leading and fast-growing express delivery company inChina,today announced that it will release its unaudited financial results for the fourth quarter ended December 31,2024 and its unaudited annual results for the fiscal year ended December 31,2024,after the U.S. market closes on March 18,2025.
ZTO's management team will host an earnings conference call at 8:30 P.M. U.S. Eastern Time on Tuesday,March 18,2025,which is 8:30 A.M. Beijing Time on Wednesday,March 19,2025.
Dial-in details for the earnings conference call are as follows:
United States:
1-888-317-6003
Hong Kong:
800-963976
Singapore:
800-120-5863
Mainland China:
4001-206115
International:
1-412-317-6061
Passcode:
9429827
A replay of the conference call may be accessible through March 25,2025 by dialing the following numbers:
United States:
1-877-344-7529
International:
1-412-317-0088
Canada:
855-669-9658
Passcode:
8404611
A live and archived webcast of the conference call will also be available at the Company's investor relations website at http://zto.investorroom.com.
About ZTO Express (Cayman) Inc.
ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) ("ZTO" or the "Company") is a leading and fast-growing express delivery company inChina. ZTO provides express delivery service as well as other value-added logistics services through its extensive and reliable nationwide network coverage inChina.
ZTO operates a highly scalable network partner model,which the Company believes is best suited to support the significant growth of e-commerce inChina. The Company leverages its network partners to provide pickup and last-mile delivery services,while controlling the mission-critical line-haul transportation and sorting network within the express delivery service value chain.
For more information,please visit http://zto.investorroom.com.
For investor inquiries,please contact:
Investor Relations
Tel: (86) 21 5980 4508
Email: ir@zto.com
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM
©copyright 2009-2020 Singapore Info Map